OP0248 Inhibition of Sclerostin with Romosozumab in Postmenopausal Women with Low Bone Mineral Density: Phase 2 Trial Results
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A136.2-A137
◽
Keyword(s):
Phase 2
◽
2015 ◽
Vol 30
(2)
◽
pp. 216-224
◽
2015 ◽
Vol 30
(9)
◽
pp. 1717-1725
◽